Scott M. Wasserman
Private Equity Investor chez Frazier Management LLC
Profil
Scott M.
Wasserman is a Venture Partner at Frazier Management LLC since 2023.
Prior to this, he was the Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023 and Vice President & Global Development at Amgen, Inc. from 2015 to 2019.
Wasserman received his undergraduate degree from Haverford College in 1992, his graduate degree from Harvard Medical School in 1997, and his undergraduate degree from Stanford University School of Medicine in 2004.
Postes actifs de Scott M. Wasserman
Sociétés | Poste | Début |
---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01/10/2023 |
Anciens postes connus de Scott M. Wasserman
Sociétés | Poste | Fin |
---|---|---|
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Directeur Général | 01/06/2023 |
AMGEN INC. | Private Equity Investor | 01/05/2019 |
Formation de Scott M. Wasserman
Harvard Medical School | Graduate Degree |
Haverford College | Undergraduate Degree |
Stanford University School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |